# US 2019/0382389 A1 · Lfa-1 inhibitor and methods of preparation and polymorph thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0382389 A1
- Document ID: US20190382389A1
- Status: Published application
- Kind: A1
- Application number: 16/247,843
- Filed: 2019-01-15
- Published: 2019-12-19
- Earliest claimed: 2012-07-25
- Assignees: Sarcode Bioscience Inc.
- Applicants: SARcode Bioscience, Inc.
- Inventors: James Robert Zeller; Sripathy Venkatraman; Elisabeth C.A. Brot; Subashree Iyer; Michael Hall
- Web page: https://patentgrep.com/patent/US20190382389A1

## CPC

- C07D 407/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 27/02: Ophthalmic agents
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07B 63/00: Purification; Separation (separation of optically-active compounds C07B57/00); Stabilisation; Use of additives
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Methods of preparation and purification of a compound of Formula I, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed.

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

A reaction mixture comprising a compound of Formula I:
or a salt thereof, and further comprising a compound of Formula AA
wherein R is a carbon-containing moiety or a silyl-containing moiety.

### Claim 17 (depends on 16)

The reaction mixture of claim 16, further comprising one or more solvents.

### Claim 18 (depends on 17)

The reaction mixture of claim 17, wherein said one or more solvents are selected from the group consisting of water, acetone, methyl ethyl ketone, dioxane, and mixtures thereof.

### Claim 19 (depends on 16)

The reaction mixture of claim 16, further comprising water and acetone.

### Claim 20 (depends on 16)

The reaction mixture of claim 16, wherein said reaction mixture is biphasic.

### Claim 21 (depends on 16)

The reaction mixture of claim 16, further comprising a base.

### Claim 22 (depends on 21)

The reaction mixture of claim 21, wherein said base is sodium hydroxide.

### Claim 23 (depends on 16)

The reaction mixture of claim 16, further comprising a phase transfer catalyst.

### Claim 24 (depends on 23)

The reaction mixture of claim 23, wherein said phase transfer catalyst is a quaternary ammonium salt.

### Claim 25 (depends on 23)

The reaction mixture of claim 23, wherein said phase transfer catalyst is tetrabutylammonium hydroxide.

### Claim 26 (depends on 16)

The reaction mixture of claim 16, wherein R is a substituted or unsubstituted group selected from lower alkyl, lower alkenyl, lower alkynyl, cyclo(lower)alkyl, cyclo(lower)alkenyl, aryl, aralkyl, heterocyclyl, and heteroaryl groups.

### Claim 27 (depends on 16)

The reaction mixture of claim 16, wherein Formula AA is:

### Claim 28 (depends on 27)

The reaction mixture of claim 27, further comprising water, acetone, sodium hydroxide, and tetrabutylammonium hydroxide, or salts thereof.

### Claim at position 15

-37. (canceled)

### Claim 38

A composition comprising a compound of Formula I:
or a salt thereof, and further comprising water and acetone.

### Claim 39 (depends on 38)

The composition of claim 38, further comprising a pH modifier, wherein said composition has a pH of between about 1 and about 5.

### Claim 40 (depends on 38)

The composition of claim 38, wherein said composition is heated above room temperature.

### Claim at position 19

-54. (canceled)
